, Tracking Stock Market Picks
Enter Symbol:
Hologic, Inc. (HOLX) [hlAlert]

up 24.63 %

Hologic, Inc. (HOLX) upgraded to Outperform with price target $19 by Barrington Research

Posted on: Wednesday,  Nov 4, 2009  9:25 AM ET by Barrington Research

Barrington Research rated Outperform Hologic, Inc. (NASDAQ: HOLX) on 11/04/2009, when the stock price was $15.06. Since then, Hologic, Inc. has
gained 24.63% of its value until Barrington Research rated HOLX Mkt Perform on 03/19/2010, when the price was $18.77.
If you would have followed this Barrington Research's recommendation on HOLX, you would have gained 24.63% of your investment in 135 days.

Hologic Inc. is a leading supplier of high quality, innovative and clinically valuable diagnostic systems and tests. The company develops, manufactures and markets X-ray bone densitometers and ultrasound bone analyzers that address a growing market for osteoporosis prevention and treatment -- a key element of women's health care. The systems are used by more leading medical schools, universities and osteoporosis opinion leaders than any other bone densitometer.

As our name implies, research plays a central role in everything we do. Whether we're dealing with sales, trading, investment banking or asset management, insightful research is indispensable in providing value to our clients. Our research provides us with a comprehensive understanding of the economy, financial markets, and individual companies, all of which are essential in recommending successful investments.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/29/2011 1:25 PM Buy
18.50 24.00
as of 12/31/2009
1 Week up  29.16 %
1 Month up  32.82 %
3 Months up  27.62 %
1 YTD up  59.91 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/4/2011 1:25 PM Hold
5/6/2010 9:25 AM Buy
16.51 20.00
5/6/2010 9:25 AM Buy
16.51 20.00
3/19/2010 10:25 AM Hold
11/4/2009 9:25 AM Buy
15.06 19.00
9/15/2009 3:25 PM Hold
3/24/2009 8:25 AM Buy
13.19 19.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy